Date:24/5/11,
M&A,
JB Chemicals & Pharmaceuticals sells its Russia/CIS over-the-counter products business to Cilag GmbH International, an arm of the global healthcare giant Johnson & Johnson, for $260 million (INR 1.17 Billion) in cash deal.
Johnson & Johnson LLC and its affiliates will market these products in Russia, the world’s eighth largest OTC market, and in the Commonwealth of Independent States (CIS), as well as in other countries.
No comments:
Post a Comment